Endothelin-1 in Health and Disease
International Journal of Molecular Sciences · 10.07.2023 · 24 (14) · 11295
DOI: 10.3390/ijms241411295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.07.2023. Verfasst von Katherine M R M Banecki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19, Endothelin-1, Chronic Pain. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Bodleian Library, University of Oxford.
Abstract (Originalsprache)
Discovered almost 40 years ago, the potent vasoconstrictor peptide endothelin-1 (ET-1) has a wide range of roles both physiologically and pathologically. In recent years, there has been a focus on the contribution of ET-1 to disease. This has led to the development of various ET receptor antagonists, some of which are approved for the treatment of pulmonary arterial hypertension, while clinical trials for other diseases have been numerous yet, for the most part, unsuccessful. However, given the vast physiological impact of ET-1, it is both surprising and disappointing that therapeutics targeting the ET-1 pathway remain limited. Strategies aimed at the pathways influencing the synthesis and release of ET-1 could provide new therapeutic avenues, yet research using cultured cells in vitro has had little follow up in intact ex vivo and in vivo preparations. This article summarises what is currently known about the synthesis, storage and release of ET-1 as well as the role of ET-1 in several diseases including cardiovascular diseases, COVID-19 and chronic pain. Unravelling the ET-1 pathway and identifying therapeutic targets has the potential to treat many diseases whether through disease prevention, slowing disease progression or reversing pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
ORCID-Profile: Kim A Dora
Förderung
- British Heart Foundation
- Bodleian Library, University of Oxford
Zitieren
APA
Banecki, K. M. R. M., & Dora, K. A. (2023). Endothelin-1 in Health and Disease. International Journal of Molecular Sciences, 24(14), 11295. https://doi.org/10.3390/ijms241411295
Vancouver
Banecki KMRM, Dora KA. Endothelin-1 in Health and Disease. International Journal of Molecular Sciences. 2023;24(14):11295. doi:10.3390/ijms241411295
BibTeX
@article{Banecki2023,
author = {Banecki, Katherine M R M and Dora, Kim A},
title = {Endothelin-1 in Health and Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {14},
pages = {11295},
doi = {10.3390/ijms241411295}
}
EUVIMED